GlioCure in the OUI Pitch selection of Oncology Partnering Convention Meet2Win 2019

GlioCure has been selected by a committee of twelve investors (ADVENT France Biotechnology, AGLAIA Oncology, ANGELS Santé, AURIGA, BPIfrance, Fondation FOURNIER-MAJOIE, GO Capital, iBionext, LSP, OMNES, SEVENTURE and SOFINNOVA) gathered by MATWIN for a short presentation at the Oncology Upward Investment Pitch session.

The OUI Pitch session will be held on May 21, 2019 from 14:00 to 17:00 in Bordeaux as part of the 5th edition of the Oncology Partnering Convention Meet2Win.

See the program